Amaris B. Clinic Unveils Unique Gynecomastia Insights from 554 Patients in Singapore

The first extensive patient data collection and analysis carried out by Dr Ivan Puah and his team at Amaris B. Clinic in Singapore, the data of 554 gynecomastia patients reveals a higher prevalence of gynecomastia in patients with higher BMI and its association with the severity of the condition.

SINGAPORE, Oct. 25, 2023 /PRNewswire/ -- Dr Ivan Puah, a liposuction doctor and Chairman of the Lipo Peer Review Committee in Singapore, boasts nearly two decades of clinical experience in addressing gynecomastia across diverse patient profiles. His innovative gynecomastia surgery approach, called 360° GTD®, modernised the male aesthetics landscape as it not only greatly minimises surgical invasiveness, scarring and downtime but also consistently produces a high patient satisfaction rate. The culmination of these achievements has led Amaris B. Clinic to be recognised as the "Gynecomastia Clinic of the Year in APAC" at the Asia-Pacific Specialist Clinic and Medical Centre Awards in May 2023.

This year, Amaris B. Clinic undertook an extensive analysis of 554 patients who had gynecomastia surgery done by Dr Ivan Puah between January 2018 and July 2023. The objective is to unravel the multifaceted factors contributing to gynecomastia, shedding new light on this medical condition.

Gynecomastia: A benign male breast disorder

Gynecomastia is a common male breast deformity characterised by abnormal breast tissue proliferation (glands and fat). This condition may manifest either unilaterally or bilaterally, leading to a spectrum of physical discomfort and emotional distress among affected individuals.

Gynecomastia patients demographics at Amaris B. Clinic Singapore

The mean age of the 554 patients Dr Ivan Puah has successfully treated for gynecomastia from January 2018 to July 2023 is 32. The oldest patient was 70, and the youngest was a 14-year-old.

Average BMI of gynecomastia patients at Amaris B. Clinic

A significant finding from Dr Ivan Puah's data analysis was that the mean body mass index (BMI) among the 554 male gynecomastia patients, most of whom were of Asian descent, was recorded at an average of 25.8, which classifies them within the "overweight" category under the WHO International Classification Of Weight Status. These findings underscore the significance of BMI in understanding and addressing gynecomastia within this patient population.

Is BMI a risk factor for gynecomastia?

There is indeed a correlation between obesity or BMI and the risk of developing gynecomastia. This is in line with many studies that have observed an association between breast enlargement and increasing BMI. This is not surprising as weight gain encourages aromatase activity in men. Aromatase activity is the enzyme activity when androgens convert into estrogen, thus causing a hormonal imbalance, which in turn will drive the development of the male breast tissue. Obesity is also associated with chronic inflammation, which can further disrupt hormone regulation.

It is important to note that while there is a correlation between obesity and gynecomastia, not all cases of gynecomastia are solely related to obesity. Physiological changes, medications, hormonal disorders, and other underlying medical conditions can also cause gynecomastia.

"Our findings have not only unveiled a compelling link between body mass index (BMI) and the prevalence of gynecomastia. It is evident that individuals with higher BMI face a substantially higher occurrence of gynecomastia. Our dedication to ongoing research will further enhance our understanding of gynecomastia, its risk factors, and its connection to BMI, ultimately contributing to the overall health and wellbeing of our patients and the wider community," explains Dr Ivan Puah.

ABOUT DR IVAN PUAH

Dr Ivan Puah is the Medical Director of Amaris B. Clinic, a medical aesthetics, sculpting and fitness clinic in Singapore. He obtained his Vaser liposuction (fundamental & hi-definition) training in Colorado and Argentina. Dr Puah has also received training in syringe liposculpture, fat grafting and thread lift by renowned French plastic surgeon, Dr Pierre Francois Fournier, and dedicated surgical training in gynecomastia surgery in San Francisco.

In Singapore, Dr Ivan Puah is accredited by the Ministry of Health to perform liposuction and serves as the Chairman of the Lipo Peer Review Committee in Singapore. He holds a Graduate Diploma in Family Dermatology from NUS, a Graduate Diploma in Acupuncture from TCMB, and a Graduate Diploma in Sports Medicine from LKCMedicine, NTU. Dr Puah is also the appointed trainer by Allergan and Merz for fellow doctors on cosmetic injectables such as neurotoxins and dermal fillers. He is also the appointed trainer for PDO thread lift and Picolaser from Venusys Medical in Singapore.

OTHER SIGNATURE AESTHETICS & SCULPTING TREATMENTS AT AMARIS B. CLINIC

Established in 2004, Amaris B. Clinic has been providing medical aesthetics and body sculpting services. Amaris B Clinic's forte lies in body sculpting - surgically removing stubborn fat pockets to sculpt and shape different areas of the body through various services offered.

Amaris B. Clinic was recognised as Body Sculpting Clinic of the Year in Asia Pacific in 2022, 2021, 2020, and 2019. The clinic was also awarded 2023 and 2022 Gynecomastia Clinic of the Year in Asia Pacific and 2023 Liposuction Clinic of the Year in Asia Pacific. The clinic also won the "2020 Integrated Healthcare Medical Centre of the Year in the Asia Pacific" by GlobalHealth Asia Pacific. The clinic has also bagged the Best Innovative Treatments for Dr Ivan Puah's proprietary liposuction technique, Vaser Lipo With MDC-sculpt® Lipo Technique from Daily Vanity's Spa & Hair Awards in 2022 and 2021, and Honeycombers' Love Local Awards 2021 - Editor's Choice Winner: Best Aesthetics Clinic In Singapore.

The clinic's signature treatments include:

• Fat Grafting
• Liposuction
• Gynecomastia Surgery
• 4D Fluid Facelift
• Sports Aesthetics
• Skin Management